CELLS, TISSUES, ORGANS, AND ANIMALS HAVING ONE OR MORE MODIFIED GENES FOR ENHANCED XENOGRAFT SURVIVAL AND TOLERANCE

CELLS, TISSUES, ORGANS, AND ANIMALS HAVING ONE OR MORE MODIFIED GENES FOR ENHANCED XENOGRAFT SURVIVAL AND TOLERANCE

CELLS, TISSUES, ORGANS, AND ANIMALS HAVING ONE OR MORE MODIFIED GENES FOR ENHANCED XENOGRAFT SURVIVAL AND TOLERANCE

CARDIAC-SPECIFIC TARGETING-PEPTIDE (CTP), COMPOSITIONS, AND USES THEREOF

PEPTIDES FOR THE TREATMENT OF TYPE 2 DIABETES

Recombinant Corynebacterium capable of producing biliverdin IX-alpha and method of producing biliverdin IX-alpha using the same

Glycated hemoglobin oxidase variant and method for measurement

Cell model for in vitro evaluation of compound-induced skin sensitization and a constructing method therefor

Method for significantly increasing lentiviral production

LIPOCALIN FUSION PARTNERS

Transgenic pig which simultaneously expresses HO-1 gene and TNFR1-Fc gene, and comprises knocked-out GGTA1 gene, and use thereof

Diagnosis and treatment of preeclampsia

Lipocalin fusion partners

Recombinant non-animal cell for making biliverdin

METHODS OF TREATING INFLAMMATION BY ADMINISTRATION OF HEME OXYGENASE-1 AND PRODUCTS OF HEME DEGRADATION

INHIBITION OF BRAIN ENZYMES INOLVED IN CEREBRAL AMYLOID ANGIOPATHY AND MACULAR DEGENERATION

Biliverdin from a non-animal source

Diagnosis and treatment of preeclampsia

INHIBITION OF BRAIN ENZYMES INVOLVED IN CEREBRAL AMYLOID ANGIOPATHY AND MACULAR DEGENERATION

INHIBITION OF BRAIN ENZYMES INVOLVED IN CEREBRAL AMYLOID ANGIOPATHY AND MACULAR DEGENERATION

INTRANASAL DELIVERY OF NUCLEIC ACID MOLECULES

Methods of treating inflammation by administration of heme oxygenase-1 and products of heme degradation

Intranasal delivery of nucleic acid molecules